Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OXY-1 System

K-Number: K223161 · 2023-02-23

ApplicantAbiomed, Inc.
Decision Date2023-02-23
Product CodeDTZ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

OXY-1 System is a medical device manufactured by Abiomed, Inc.. It received FDA 510(k) clearance on 2023-02-23 under approval number K223161. The device is classified under product code DTZ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OXY-1 System?

OXY-1 System is a medical device that received FDA 510(k) clearance on 2023-02-23. It is manufactured by Abiomed, Inc.. The 510(k) number is K223161.

When was OXY-1 System approved by the FDA?

OXY-1 System received FDA 510(k) clearance on 2023-02-23, under approval number K223161.

What company makes OXY-1 System?

OXY-1 System is manufactured by Abiomed, Inc..

What is the FDA product code for OXY-1 System?

The FDA product code for OXY-1 System is DTZ.

Other Devices by Abiomed, Inc.

View all 11 devices →

Related Devices (Code: DTZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.